HopeStage
Back to all studies
TerminatedNCT04260607

Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department

Medication studyAges 18–89United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 89 years.

Listed locations
Marine Corps Base Camp LejeuneSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 14, 2020
Recruitment status
Terminated
Enrollment listed in the registry
1
Sponsor
Naval Medical Center Camp Lejeune
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 89 Years
Official registry ID
NCT04260607
Official title
Show the full official title

Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department

Recruitment & locations

Terminated

Marine Corps Base Camp Lejeune

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Naval Medical Center Camp Lejeune, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Ketamine Hydrochloride and Normal saline.

Who can participate?

Listed age limits: 18 years to 89 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies